Blog
Insights, updates, and perspectives on the future of generic drug repurposing
Cheap, effective treatments for cancer already exist, so why don’t you know about them?
In her Boston Globe Op-Ed, Reboot Rx Founder and CEO Laura Kleiman discusses how generic drugs hold so much untapped potential to be repurposed for cancer and other diseases, yet this is not being realized because of the lack of market incentives and funding.